BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37976235)

  • 1. Global consensus process to establish a core dataset for hidradenitis suppurativa registries.
    Wainman HE; Chandran NS; Frew JW; Garg A; Gibbons A; Gierbolini A; Horvath B; Jemec GB; Kirby B; Kirby J; Lowes MA; Martorell A; McGrath BM; Naik HB; Oon HH; Prens E; Sayed CJ; Thorlacius L; Van der Zee HH; Villumsen B; Ingram JR
    Br J Dermatol; 2024 Mar; 190(4):510-518. PubMed ID: 37976235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus Statement.
    Mastacouris N; Tannenbaum R; Strunk A; Koptyev J; Aarts P; Alhusayen R; Bechara FG; Benhadou F; Bettoli V; Brassard A; Brown D; Choon SE; Coutts P; da Silva DLF; Daveluy S; Dellavalle RP; Del Marmol V; Emtestam L; Gebauer K; George R; Giamarellos-Bourboulis EJ; Goldfarb N; Hamzavi I; Hazen PG; Horváth B; Hsiao J; Ingram JR; Jemec GBE; Kirby JS; Lowes MA; Marzano AV; Matusiak L; Naik HB; Okun MM; Oon HH; Orenstein LAV; Paek SY; Pascual JC; Fernandez-Peñas P; Resnik BI; Sayed CJ; Thorlacius L; van der Zee HH; van Straalen KR; Garg A
    JAMA Dermatol; 2023 Nov; 159(11):1258-1266. PubMed ID: 37755725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process.
    Thorlacius L; Ingram JR; Villumsen B; Esmann S; Kirby JS; Gottlieb AB; Merola JF; Dellavalle R; Nielsen SM; Christensen R; Garg A; Jemec GBE;
    Br J Dermatol; 2018 Sep; 179(3):642-650. PubMed ID: 29654696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes.
    Thorlacius L; Ingram JR; Garg A; Villumsen B; Esmann S; Kirby JS; Gottlieb AB; Merola JF; Dellavalle R; Christensen R; Jemec GB
    BMJ Open; 2017 Feb; 7(2):e014733. PubMed ID: 28219961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards global consensus on core outcomes for hidradenitis suppurativa research: an update from the HISTORIC consensus meetings I and II.
    Thorlacius L; Garg A; Ingram JR; Villumsen B; Theut Riis P; Gottlieb AB; Merola JF; Dellavalle R; Ardon C; Baba R; Bechara FG; Cohen AD; Daham N; Davis M; Emtestam L; Fernández-Peñas P; Filippelli M; Gibbons A; Grant T; Guilbault S; Gulliver S; Harris C; Harvent C; Houston K; Kirby JS; Matusiak L; Mehdizadeh A; Mojica T; Okun M; Orgill D; Pallack L; Parks-Miller A; Prens EP; Randell S; Rogers C; Rosen CF; Choon SE; van der Zee HH; Christensen R; Jemec GBE
    Br J Dermatol; 2018 Mar; 178(3):715-721. PubMed ID: 29080368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global Harmonization of Morphological Definitions in Hidradenitis Suppurativa for a Proposed Glossary.
    Frew JW; Lowes MA; Goldfarb N; Butt M; Piguet V; O'Brien E; Ingram J; Jemec GBE; Tan J; Zouboulis C; Alavi A; Kirby JS
    JAMA Dermatol; 2021 Apr; 157(4):449-455. PubMed ID: 33688910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
    Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
    Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectious Disease Screening prior to Systemic Immunomodulatory Therapy in Hidradenitis Suppurativa: Consensus Guidelines from the Asia-Pacific Hidradenitis Suppurativa Foundation.
    Kozera EK; Porter M; Paek SY; Mintoff D; McMeniman E; Oon HH; Chandran NS; Glasenhardt K; Ring HC; Frew JW
    Dermatology; 2024; 240(3):494-506. PubMed ID: 37963431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expert consensus on priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa: a Delphi consensus study.
    Yamanaka-Takaichi M; Revankar R; Shih T; Gall M; Hsiao JL; Shi VY; Alavi A
    Arch Dermatol Res; 2023 Sep; 315(7):2129-2136. PubMed ID: 36951970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hidradenitis suppurativa epidemiology: from the first Italian registry in 2009 to the most recent epidemiology updates - Italian Registry Hidradenitis Suppurativa project 2.
    Bettoli V; Cazzaniga S; Scuderi V; Zedde P; Di Landro A; Naldi L;
    J Eur Acad Dermatol Venereol; 2019 Oct; 33 Suppl 6():4-6. PubMed ID: 31535758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries.
    Gerbens LA; Boyce AE; Wall D; Barbarot S; de Booij RJ; Deleuran M; Middelkamp-Hup MA; Roberts A; Vestergaard C; Weidinger S; Apfelbacher CJ; Irvine AD; Schmitt J; Williamson PR; Spuls PI; Flohr C
    Trials; 2017 Feb; 18(1):87. PubMed ID: 28241851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Bariatric Surgery Core Data Set for an International Registry.
    Coulman KD; Chalmers K; Blazeby J; Dixon J; Kow L; Liem R; Pournaras DJ; Ottosson J; Welbourn R; Brown W; Avery K
    Obes Surg; 2023 May; 33(5):1463-1475. PubMed ID: 36959437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International Consortium of Vascular Registries Consensus Recommendations for Peripheral Revascularisation Registry Data Collection.
    Behrendt CA; Bertges D; Eldrup N; Beck AW; Mani K; Venermo M; Szeberin Z; Menyhei G; Thomson I; Heller G; Wigger P; Danielsson G; Galzerano G; Lopez C; Altreuther M; Sigvant B; Rieß HC; Sedrakyan A; Beiles B; Björck M; Boyle JR; Debus ES; Cronenwett J
    Eur J Vasc Endovasc Surg; 2018 Aug; 56(2):217-237. PubMed ID: 29776646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editor's Choice - Recommendations for Registry Data Collection for Revascularisations of Acute Limb Ischaemia: A Delphi Consensus from the International Consortium of Vascular Registries.
    Behrendt CA; Björck M; Schwaneberg T; Debus ES; Cronenwett J; Sigvant B;
    Eur J Vasc Endovasc Surg; 2019 Jun; 57(6):816-821. PubMed ID: 31128987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TREatment of ATopic eczema (TREAT) Registry Taskforce: an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema photo- and systemic therapy registries.
    Gerbens LAA; Apfelbacher CJ; Irvine AD; Barbarot S; de Booij RJ; Boyce AE; Deleuran M; Eichenfield LF; Hof MH; Middelkamp-Hup MA; Roberts A; Schmitt J; Vestergaard C; Wall D; Weidinger S; Williamson PR; Flohr C; Spuls PI;
    Br J Dermatol; 2019 Apr; 180(4):790-801. PubMed ID: 29761486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical Procedural Definitions for Hidradenitis Suppurativa Developed by Expert Delphi Consensus.
    Bui H; Bechara FG; George R; Goldberg S; Hamzavi I; Kirby JS; Saylor D; Sayed CJ
    JAMA Dermatol; 2023 Apr; 159(4):441-447. PubMed ID: 36811866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Hidradenitis Suppurativa Evaluation Study (THESEUS): protocol for a prospective cohort study.
    Bates J; Stanton H; Cannings-John R; Thomas KS; Leighton P; Howells LM; Rodrigues J; Howes R; Collier F; Harris C; Gibbons A; Thomas-Jones E; Hood K; Ingram JR
    BMJ Open; 2022 Apr; 12(4):e060815. PubMed ID: 35450918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electronic Patient-Reported Outcomes in Hidradenitis Suppurativa: Content Validity and Usability of the Electronic Hidradenitis Suppurativa Symptom Daily Diary, Hidradenitis Suppurativa Symptom Questionnaire, and Hidradenitis Suppurativa Quality of Life Questionnaire.
    Ingram JR; Ciaravino V; Rolleri R; Pansar I; Dias-Barbosa C; Kirby JS
    Dermatology; 2024; 240(1):65-76. PubMed ID: 37820596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expert consensus on unmet needs, referral criteria and treatment goals for hidradenitis suppurativa in Saudi Arabia.
    Eshmawi MT; Yousef Al-Mudaiheem H; Fatani M; Binamer Y; Alajlan M; Alharithy R; Alotaibi H; Almohanna HM; Alsantali A; Madani A; Al-Faraidy N; Bechara FG; Hamden Al-Jedaie A
    J Dermatolog Treat; 2024 Dec; 35(1):2353693. PubMed ID: 38862417
    [No Abstract]   [Full Text] [Related]  

  • 20. Pain measurement in painful skin conditions and rheumatoid arthritis randomized controlled trials: a scoping review to inform pain measurement in hidradenitis suppurativa.
    Hasan SB; Gendra R; James J; Morris D; Orenstein LAV; Ingram JR
    Br J Dermatol; 2022 Dec; 187(6):846-854. PubMed ID: 35962565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.